Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine > Articles > Policy > OncoCorridor
  • Articles
  • Policy

OncoCorridor

  • 22 April 2026
  • Gevorg Tamamyan
OncoCorridor
Total
0
Shares
0
0
0
0
0

As a medical student, we had a lecture on how to deliver bad news.
Then, as an oncology fellow, we had it again.
And as frontline clinicians, we practice it every day.

“Your child has leukemia…
You have cancer…
Your child has Ewing sarcoma…
You have lymphoma…
But there is a big chance you will get through. A real chance to be cured.”

But how do you deliver that news in a war zone?

What do you say?

“Your child has leukemia. There is an 85% chance to be cured, but because of the war, because of the bombs, there is no chance. The hospital is destroyed. The chemotherapy is not available. There is no way to get the drugs.”

And what do you say to a doctor, whose patient just rang the bell, completed treatment  and on the way home, a bomb killed him?

What do you say?
Sorry?

In your entire career, you may save hundreds of lives.
And then, in a moment, a bomb kills more.

Yesterday, I was speaking with a friend.
He was sharing the results of a new immunotherapy combination.

“You know,” he said, “more than 40% of patients, those who failed all lines of therapy, refractory patients, are still alive after two years.”

He was excited.

At the same time, I was reading reports about cancer patients in war-affected regions — about their struggles, their pain, their suffering.

A person fighting cancer with everything they have and then hit by war.

So what should we do?

Speak out? Yes.
But what else?

When war closes doors, we must open corridors.

OncoCorridor.

On May 18th, in Geneva, during the World Health Assembly, OncoDaily, together with the Institute of Cancer and Crisis, is launching OncoCorridor — a global network connecting cancer patients in conflict zones to treatment centers worldwide.

OncoCorridor is the direct operationalization of a landmark manifesto published in The Lancet, co-authored by the WHO Director-General, calling for exactly this kind of mechanism.

We must act now.

No patient should die of curable cancer because a war stood in the way.

We have the treatments.
We have the hospitals.
We just need to connect them to the people who need them.

Remarkable work has been done by individual organizations.
But no coordinated global mechanism exists to systematically connect treatment capacity to patients in conflict zones — until now.

The time has come.

We cannot wait.

We know what to do. We just have to do it.

The next time a doctor stands at that bedside, searching for words — there will be an answer.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • cancer care access
  • cancer patients in war zones
  • cancer survival rates
  • Cancer Treatment Access
  • canerworld
  • conflict zone medicine
  • crisis medicine
  • cross-border healthcare
  • Ewing sarcoma
  • Geneva health summit
  • Global Health Equity
  • Global Oncology
  • healthcare access inequality
  • healthcare systems failure
  • humanitarian healthcare
  • immunotherapy breakthroughs
  • Institute of Cancer and Crisis
  • leukemia treatment
  • lymphoma care
  • medical humanitarian response
  • newsletter
  • OncoCorridor
  • oncodaily
  • oncology in crisis
  • Oncology Innovation
  • Oncology Leadership
  • patient access to treatment
  • Pediatric Oncology
  • The Lancet oncology
  • war and healthcare
  • WHO global health
  • World Health Assembly
Gevorg Tamamyan

Previous Article
  • News

CancerWorld #114 (April 2026)

  • 20 April 2026
  • Knarik Arakelyan
View Post
You May Also Like
View Post
  • Articles
  • Delivery of Care

Lived Experience of People Affected by Cancer

  • Adrian Pogacian
  • 31 March 2026
View Post
  • Articles
  • Profiles

Translating Global Excellence into Local Impact: Dr Fatjona Kraja and the Challenge of  Transforming Radiation Oncology in Albania

  • Knarik Arakelyan
  • 27 March 2026
View Post
  • Articles
  • Profiles

“Hope is Constant “: From Isolation and Fear to Connection, Purpose, and Global Impact

  • Kevin Donaghy
  • 25 March 2026
View Post
  • Articles
  • Medicine

Michael Gnant at the Crossroads of Oncology: Precision, Restraint, and the Courage to Challenge Orthodoxy

  • Yeva Margaryan
  • 23 March 2026
View Post
  • Articles
  • Profiles

From Dalian to Houston and Back to Yemen: Bridging the Global Oncology Divide

  • Mohammed Safi
  • 21 March 2026
View Post
  • Medicine
  • News

The Day Immunotherapy Went Off-Patent

  • Amalya Sargsyan
  • 18 March 2026
View Post
  • Articles
  • Policy
  • Profiles

Leading with Listening: Why Isabel Rubio Believes Europe’s Cancer Future Depends on Trust, Equity, and Political Courage

  • Knarik Arakelyan
  • 16 March 2026
Bente Mikkelsen
View Post
  • Articles
  • Profiles

Bente Mikkelsen: “Success is Something We Build Together”

  • Gevorg Tamamyan
  • 13 March 2026
search
CancerWorld #114 Download CancerWorld #113 Download CancerWorld #112 Download CancerWorld #111 Download CancerWorld #110 Download CancerWorld Special Issue Download CancerWorld #109 Download CancerWorld #108 Download CancerWorld #107 Download CancerWorld #106 Download CancerWorld #105 Download CancerWorld #104 Download CancerWorld #103 Download CancerWorld #102 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • CancerWorld #114 (April 2026)
    • 20 April 2026
  • The Day Immunotherapy Went Off-Patent
    • 18 March 2026
  • CancerWorld #113 (March 2026)
    • 9 March 2026
  • Rethinking Immunotherapy for Pancreatic Cancer: A Universal Approach
    • 16 February 2026
  • CancerWorld #112 (February 2026)
    • 7 February 2026
Article
  • OncoCorridor
    • 22 April 2026
  • Lived Experience of People Affected by Cancer
    • 31 March 2026
  • Translating Global Excellence into Local Impact: Dr Fatjona Kraja and the Challenge of  Transforming Radiation Oncology in Albania
    • 27 March 2026
Social

Would you follow us ?

Contents
  • Translating Global Excellence into Local Impact: Dr Fatjona Kraja and the Challenge of  Transforming Radiation Oncology in Albania
    • 27 March 2026
  • “Hope is Constant “: From Isolation and Fear to Connection, Purpose, and Global Impact
    • 25 March 2026
  • From Dalian to Houston and Back to Yemen: Bridging the Global Oncology Divide
    • 21 March 2026
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.